HD Labs | Semaglutide 10mg | Compound Peptide Pen
Advanced GLP-1 Receptor Research Compound
HD LABS Semaglutide Compound Peptide Pen is an investigational GLP-1 receptor research compound studied in laboratory environments for its role in metabolic signalling pathways, glucose regulation mechanisms, and appetite-related endocrine responses.
Semaglutide is widely referenced in scientific research exploring incretin hormone activity, insulin secretion dynamics, and energy balance regulation within controlled experimental and biochemical models.
Developed as a 10mg compound peptide pen, this formulation is designed for laboratory preparation and controlled research applications where GLP-1 receptor activity and metabolic pathway investigation are of scientific interest.
HD LABS Semaglutide 10mg Compound Peptide Pen
• GLP-1 receptor research compound studied in metabolic signalling models
• Investigated in glucose regulation and insulin response research
• Of interest in appetite signalling and energy balance studies
• Explored in incretin hormone pathway research environments
• 10mg peptide pen format designed for laboratory preparation use
• High-purity investigational formulation from HD LABS
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
